About Incept BioSystems
Incept BioSystems is a company based in Ann Arbor (United States) founded in 2005 was acquired by Origio in December 2010. Incept BioSystems has raised $3.29 million across 9 funding rounds from investors including HHS, Plymouth Growth and Michigan Economic Development. Incept BioSystems operates in a competitive market with competitors including 10X Genomics, Mission Bio, MaxCyte, SQZBiotech and Cellares, among others.
- Headquarter Ann Arbor, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Incept BioSystems
Incept BioSystems has successfully raised a total of $3.29M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $127.61 thousand completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Incept BioSystems
Incept BioSystems has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Plymouth Growth and Michigan Economic Development.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia
|
Locked | Locked | Locked | |
|
Growth stage tech & offline focused VC firm funding companies in the US
|
Locked | Locked | Locked | |
|
Finger Interests, Ltd. is operated as a family office in Houston.
|
Locked | Locked | Locked |
Investor details for Incept BioSystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Incept BioSystems
Investment portfolio details for Incept BioSystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Incept BioSystems
Detailed financials for Incept BioSystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Incept Biosystems Comparisons
Peer comparison for Incept BioSystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Incept BioSystems
Incept BioSystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, MaxCyte, SQZBiotech and Cellares, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| Locked | Locked | Locked |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| Locked | Locked | Locked |
Instrument systems for cell processing and modification are provided.
|
|
| Locked | Locked | Locked |
Cell therapies are developed using proprietary Cell Squeeze technology.
|
|
| Locked | Locked | Locked |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| Locked | Locked | Locked |
Optical tweezers instruments for single-molecule analysis are manufactured.
|
Detailed competitors of Incept BioSystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Incept Biosystems
Complete news archive for Incept BioSystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Incept BioSystems
Incept BioSystems was founded in 2005.
Incept BioSystems is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Incept BioSystems is a funded company, having raised a total of $3.29M across 9 funding rounds to date.
Incept BioSystems was founded in 2005 in Ann Arbor, United States, and operates within the biotechnology sector focused on assisted reproductive technologies. Proprietary microscale SMART systems are utilized to develop devices that replicate in vivo conditions for embryo and oocyte culture. These tools support in vitro manipulation and viability enhancement of high-value cells, aiding IVF treatments in reproductive labs across the domain of inceptbio.com.
Incept BioSystems's top competitors include MaxCyte, 10X Genomics and Mission Bio.
Incept BioSystems has 6 investors. Key investors include HHS, Plymouth Growth, Michigan Economic Development, Venture Investors, and Finger Interests.